Canada Health Infoway has officially announced that the PrescribeIT service will end on May 29, 2026. This national e-prescribing platform, which allowed physicians and nurse practitioners to send prescriptions electronically from their EMR directly to pharmacies, will cease operations as part of a shift toward an open-standards e-prescribing model.
This change creates both challenges and opportunities. Understanding the timeline, implications, and preparation steps is essential to maintain safe, efficient prescribing workflows with minimal disruption to patient care.
Launched in 2018, PrescribeIT was developed by Canada Health Infoway to replace fax and paper prescriptions with a secure, national electronic solution. Despite technical success and integration with many EMRs and pharmacy systems, the service did not achieve the widespread adoption needed for long-term sustainability.
After consultations with provinces, territories, and stakeholders, Infoway decided to wind down the centrally operated service. Instead, Canada is moving to a more flexible open-standards approach that allows provinces, EMR vendors, and technology providers to develop interoperable e-prescribing solutions tailored to local needs.
The service will remain fully operational until May 29, 2026, at 11:59 PM EST. After this date, Infoway will no longer operate PrescribeIT, and a national e-prescribing standard will be made publicly available to support the transition.
Practices currently using PrescribeIT for new prescriptions, renewals, and certain monitored drugs (including TPP Type 1 medications under existing exemptions) will need to adapt. The exemption tied specifically to PrescribeIT for electronically transmitting monitored drugs will also end with the service.
This transition affects family physicians, specialists, nurse practitioners, and multidisciplinary teams who have integrated electronic prescribing into their daily workflows.
The end of PrescribeIT does not mean the end of e-prescribing in Canada. However, it will require adjustments in how prescriptions are transmitted securely and compliantly.
Main implications include:
The move to open standards e-prescribing offers greater flexibility. Provinces and vendors can now innovate faster, potentially leading to better integration with Canada’s existing digital health infrastructure and improved support for virtual care and team-based models.
Canadian healthcare providers should start preparing well before the May 2026 deadline. Here’s a practical checklist:
GoodX Healthcare clients benefit from dedicated support to align their EMR with these evolving requirements while minimizing disruption to clinical workflows.
The PrescribeIT wind-down reflects broader realities in Canadian digital health: national platforms often struggle with adoption and sustainable funding across jurisdictions. The open-standards model aims to overcome these barriers by promoting interoperability without relying on a single central service.
This approach could accelerate innovation, giving Canadian providers access to more tailored, efficient tools that better integrate with provincial programs, OHIP billing, and team-based care models.
Ultimately, the goal stays the same, reducing medication errors, improving patient safety, enhancing privacy, and freeing up valuable time for direct patient care.
At GoodX Healthcare, we provide PHIPA-compliant EMR solutions designed specifically for healthcare providers, including family practices, specialists, and multidisciplinary teams. Our platform focuses on reliability, efficiency, and adaptability during periods of regulatory and technological change.
We actively track developments related to the PrescribeIT service ending and work closely with technology partners to ensure continuity in prescribing workflows. Whether you need guidance on current integrations, preparation for open-standards e-prescribing, or support with OHIP billing and practice optimization, our team is ready to assist.
If your practice is evaluating EMR options or planning for smoother digital transitions, GoodX offers secure data migration and ongoing compliance support.
The PrescribeIT service ending on May 29, 2026 marks an important shift in Canada’s approach to e-prescribing. By taking proactive steps now, especially engaging your EMR vendor and staying informed about the upcoming national standard, healthcare providers can ensure a smooth transition with continued focus on medication safety and patient care.
Change is inevitable in healthcare technology, but preparation transforms potential disruption into an opportunity for improved workflows and better outcomes.
Stay updated through official channels from Canada Health Infoway and regulatory bodies. For personalized support with your EMR during this transition, reach out to the GoodX Healthcare team.
This article is for informational purposes only and does not replace professional regulatory or legal advice. Consult your EMR provider, college, and legal advisor for practice-specific guidance. Information is current as of April 2026.